An Open, Phase IV, Multicentric Study, Evaluating Safety and Efficacy of Ribavirin (Copegus®) and Peginterferon Alfa-2a (Pegasys®) Combination in Specific Groups
Phase of Trial: Phase IV
Latest Information Update: 25 May 2017
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C
- Focus Expanded access; Therapeutic Use
- Sponsors Roche
- 18 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jan 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 05 Dec 2008 New trial record.